Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
40.59
-0.52 (-1.26%)
At close: Jun 13, 2025, 4:00 PM
40.30
-0.29 (-0.71%)
After-hours: Jun 13, 2025, 7:21 PM EDT
Revolution Medicines Employees
Revolution Medicines had 534 employees as of December 31, 2024. The number of employees increased by 156 or 41.27% compared to the previous year.
Employees
534
Change (1Y)
156
Growth (1Y)
41.27%
Revenue / Employee
n/a
Profits / Employee
-$1,306,191
Market Cap
7.56B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
RVMD News
- 4 weeks ago - Revolution Medicines Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating Daraxonrasib in Previously Treated Patients with RAS Mutant Non-Small Cell Lung Cancer - GlobeNewsWire
- 5 weeks ago - Revolution Medicines, Inc. (RVMD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewsWire
- 6 weeks ago - Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025 - GlobeNewsWire
- 6 weeks ago - Why Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday? - Benzinga
- 6 weeks ago - Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting - GlobeNewsWire
- 2 months ago - Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 2 months ago - Revolution Medicines to Participate in April 2025 Investor Conferences - GlobeNewsWire